83
Participants
Start Date
February 10, 2016
Primary Completion Date
February 25, 2018
Study Completion Date
February 25, 2018
Tideglusib
Administered orally after dispersion in approximately 100 ml of water at dose levels of 400 to 1000 mg
Placebo
Administered orally after dispersion in approximately 100 ml of water
McMaster University, Offord Centre for Child Studies, Hamilton
University of Western Ontario, Lawson Health Research Institute, London
Holland Bloorview Kids Rehabilitation Hospital, Toronto
McMaster University
OTHER
Western University, Canada
OTHER
Unity Health Toronto
OTHER
University of Toronto
OTHER
Holland Bloorview Kids Rehabilitation Hospital
OTHER